MarketCapTrends
VTVT
vTv Therapeutics Inc. (VTVT)
NASDAQ · Healthcare

vTv Therapeutics Inc. Shareholder Equity 2013–2025

vTv Therapeutics Inc. annual/quarterly shareholder equity history from 2014 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • vTv Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 64.4M, a 428.22% increase year-over-year.
  • vTv Therapeutics Inc. shareholder equity for 2025 were 64.4M, a 428.22% increase from 2024.
  • vTv Therapeutics Inc. shareholder equity for 2024 were 12.2M, a 149.43% decrease from 2023.
  • vTv Therapeutics Inc. shareholder equity for 2023 were -24.7M, a 129.80% increase from 2022.
  • vTv Therapeutics Inc. shareholder equity for 2022 were -10.7M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
vTv Therapeutics Inc. Annual Shareholder Equity (Millions of US $)
2025$64
2024$12
2023$-25
2022$-11
2021$-10
2020$-80
2019$-49
2018$-83
2017$-151
2016$-91
2015$-78
2014$-499
vTv Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$64
2024-12-31$12
2023-12-31$-25
2022-12-31$-11
2021-12-31$-10
2020-12-31$-80
2019-12-31$-49
2018-12-31$-83
2017-12-31$-151
2016-12-31$-91
2015-12-31$-78
2014-12-31$-499

vTv Therapeutics Inc. Shareholder Equity — FAQ

vTv Therapeutics Inc. (VTVT) shareholder equity over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see VTVT's shareholder equity history?

The chart and table above show vTv Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.